Cervical cancer vaccine development
نویسندگان
چکیده
منابع مشابه
Progress in the Development of a Cervical Cancer Vaccine
Persistent infection by 'high risk' genotypes of human papilloma virus (HPV) is necessary but not sufficient for the development of over 98% of cervical cancers. Thus the development of vaccines that prevent HPV transmission represent an important opportunity to prevent cervical cancer. There are several prophylactic HPV vaccine formulations based upon L1 virus-like particles (VLPs) currently i...
متن کاملCervical cancer
سرویکس یا گردن رحم قسمتی از اندام تولید زنانه است که دهانه آن به داخل واژن باز می شود. بعضی اعمال آن عبارتند از : تولید مواد نرم کننده واژن - تولید موکوس که کمک به حرکت اسپرم می کند- حفظ جنین در رحم در طول بارداری
متن کاملAlternative Vaccine Strategies for Cervical Cancer
Cervical cancer, caused by Human Papillomavirus (HPV) is the third largest cause of female mortality over the world with an estimated 500,000 cases and 270,000 deaths annually [1]. Nevertheless there are only two vaccines are available in the world market to protect cervical cancer. Gardasil® (Merck, USA)) and Cervarix® (GlaxoSmithKline, UK) are both Virus Like Particle (VLP) based vaccines and...
متن کاملCervical cancer and the human papillomavirus vaccine.
Background As a former sufferer from cervical cancer, I obviously gave a huge whoop of joy at the recent announcement about the human papillomavirus (HPV) vaccine. At last a simple, effective weapon to use against the disease. What’s not to like? But to be frank, I was sure I’d be a lone voice, at least in the wilderness of the lay domain. In an age when the fpa’s (Family Planning Association) ...
متن کاملCervical cancer vaccine as a priority of public health practices in Iran
Cervical cancer is the third most common cancer in women. In poor countries, it is the second cause of cancer death [1]. According to official report of World Health Organization, about 500,000 new cases of cervical cancer were recorded each year that more than half of them are leading to death. 80 percent of new cases are occurred in developing countries [2].
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Sexual Health
سال: 2010
ISSN: 1448-5028
DOI: 10.1071/sh09132